M&A Deal Summary |
|
|---|---|
| Date | 2013-12-24 |
| Target | Ikaria |
| Sector | Life Science |
| Buyer(s) |
Madison Dearborn Partners
Fifth Street Capital New Mountain Capital Athyrium Capital Management |
| Deal Type | Buyout (LBO, MBO, MBI) |
| Deal Value | 1.6B USD |
| Advisor(s) | Credit Suisse Investment Banking Morgan Stanley (Financial) Fried Frank Harris Shriver & Jacobson LLP Wilmer Cutler Pickering Hale and Dorr LLP (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 1992 |
| PE ASSETS | 28.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
Madison Dearborn Partners (MDP) is a large private equity firm that targets buyouts of private or publicly held companies, divestitures of larger companies, recapitalizations of family-owned or closely-held companies, acquisition-oriented financings, and financings to fund internal growth. MDP's target investment size is $100 to $600 million in buyout oriented transactions and $100 to $400 million in growth capital commitments. Areas of interest include basic industries (natural resources, chemicals, energy and power, automotive, building products, food, metals and mining, refining, paper, packaging and forest products, and general manufacturing), as well as communications, consumer products/services, financial services, and healthcare. Madison Dearborn Partners was formed in 1992 and is based in Chicago, Illinois.
| DEAL STATS | # |
|---|---|
| Overall | 59 of 97 |
| Sector (Life Science) | 1 of 2 |
| Type (Buyout (LBO, MBO, MBI)) | 23 of 31 |
| State (New Jersey) | 1 of 1 |
| Country (United States) | 53 of 83 |
| Year (2013) | 4 of 4 |
| Size (of disclosed) | 6 of 23 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-09-03 |
Yankee Candle
South Deerfield, Massachusetts, United States Yankee Candle, is a manufacturer, wholesaler and retailer of premium scented candles. |
Sell | $1.8B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-03-03 |
Sorenson Communications
Salt Lake City, Utah, United States Sorenson Communications is a provider of communication offerings including the Sorenson Video Relay Service (VRS), Sorenson IP Relay (siprelay) and Sorenson videophones. Sorenson Communications’ Sorenson VRS enables deaf and hard-of-hearing callers to conduct video relay conversations through a qualified American Sign Language (ASL) interpreter. |
Sell | - |
Fifth Street Capital is a public investment firm focused on providing mezzanine financing to support expansions, acquisitions, recapitalizations, and management buyouts of middle-market US based companies. Fifth Street looks to invest between $5 and $50 million per transaction. Sectors of interest include consumer products, healthcare services, manufacturing, medical device manufacturing, food services, business services, restaurants, speciality retail, logistics, and value added distribution. Fifth Street Capital is based in White Plains, New York.
| DEAL STATS | # |
|---|---|
| Overall | 69 of 70 |
| Sector (Life Science) | 1 of 1 |
| Type (Buyout (LBO, MBO, MBI)) | 27 of 27 |
| State (New Jersey) | 3 of 3 |
| Country (United States) | 68 of 69 |
| Year (2013) | 5 of 5 |
| Size (of disclosed) | 1 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-11-01 |
CTM Group
Salem, New Hampshire, United States CTM Group, Inc. is a global provider of managed entertainment and souvenir solutions for tourist destination and other high-traffic venues, including theme and amusement parks, zoos, aquariums, museums, and retail locations worldwide. CTM has an international network of blue-chip venue partners and more than 10,000 pieces of installed equipment in over 2,000 popular venues. CTM is the provider of choice for entertainment and souvenir concepts at iconic tourist and retail destinations. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-03-04 |
OnCourse Learning
Brookfield, Wisconsin, United States OnCourse Learning is a provider of professional education to financial institutions providing banking and credit union governance, risk, and compliance (GRC) training. OnCourse Learning was founded in 2007 and is headquartered in Brookfield, Wisconsin. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 2000 |
| PE ASSETS | 35.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
New Mountain Capital is a private investment firm focused on investment in public and private companies in a variety of industries. New Mountain generally invests $100 to $500 million per transaction and looks for businesses with strong market positions and high barriers to entry. New Mountain also prefers businesses that succeed in both good and bad economies. Sectors of interest include education, healthcare, business services, federal IT services, media, software, consumer products, logistics, financial services and technologies, and energy. New Mountain Capital was formed in 2000 and is based in New York City.
| DEAL STATS | # |
|---|---|
| Overall | 30 of 91 |
| Sector (Life Science) | 1 of 3 |
| Type (Buyout (LBO, MBO, MBI)) | 10 of 14 |
| State (New Jersey) | 1 of 5 |
| Country (United States) | 26 of 87 |
| Year (2013) | 4 of 4 |
| Size (of disclosed) | 4 of 13 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-12-02 |
Medical Specialties Distributors
Stoughton, Massachusetts, United States Medical Specialties Distributors LLC is a provider of infusion products, supplies, biomedical services and technology solutions to the growing home infusion therapy market. Medical Specialties Distributors LLC was founded in 1982 and is based in Stoughton, Massachusetts. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-01-29 |
Inmar
Winston-Salem, North Carolina, United States Inmar operates intelligent commerce networks, connecting offline and online transactions in real time for retailers, manufacturers and trading partners across multiple industries. In addition, Inmar’s platforms generate meaningful data and enable the Company to provide clients with actionable analytics and insights to meet the evolving needs of shoppers, patients and businesses. Inmar was founded in 1980 and is based in Winston-Salem, North Carolina |
Sell | - |
| Category | Asset Manager |
|---|---|
| Founded | 2008 |
| PE ASSETS | 3.7B USD |
| Size | Large |
| Type | Sector Focused |
Athyrium Capital Management is a large asset manager focused on the healthcare sector. Athyrium invests in a wide range of financial instruments including royalties, structured credit, and equities as well as select special situations. Athyrium Capital was established in 2008 and is headquartered in New York City.
| DEAL STATS | # |
|---|---|
| Overall | 8 of 44 |
| Sector (Life Science) | 5 of 22 |
| Type (Buyout (LBO, MBO, MBI)) | 1 of 4 |
| State (New Jersey) | 1 of 4 |
| Country (United States) | 7 of 39 |
| Year (2013) | 4 of 4 |
| Size (of disclosed) | 3 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-12-20 |
Universal Biosensors
Rowville, Australia Universal Biosensors operates as a biosensors company primarily in Australia. The company focuses on the development, manufacture, and commercialization of point-of-use devices for measuring analytes across various industries. Universal Biosensors was founded in 2001 and is based in Rowville, Australia. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-05-29 |
Travere Therapeutics
San Diego, California, United States Travere Therapeutics is a fully integrated biopharmaceutical company dedicated to delivering life-changing therapies to people living with rare diseases who have few, if any, treatment options. The Company's approach centers on its pipeline featuring clinical-stage assets targeting rare diseases with significant unmet medical needs, including sparsentan for focal segmental glomerulosclerosis (FSGS), a disorder characterized by progressive scarring of the kidney often leading to end-stage renal disease, and RE-024 for pantothenate kinase-associated neurodegeneration (PKAN), a life-threatening neurological disorder that typically begins in early childhood. Research exploring the potential of early-stage assets in several rare diseases is also underway. Travere Therapeutics was founded in 2011 and is based in San Diego, California. |
Buy | - |
